Sudhakar Ramakrishna - 05 Nov 2025 Form 4 Insider Report for CARDINAL HEALTH INC (CAH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Nov 2025, 16:21:50 UTC
Prior SEC filing
30 Sep 2025
Next SEC filing
09 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James E. Barnett, Attorney-in-fact

Key filing fact

Sudhakar Ramakrishna filed Form 4 for CARDINAL HEALTH INC (CAH) on 06 Nov 2025.

Key facts

  • This page summarizes Sudhakar Ramakrishna's Form 4 filing for CARDINAL HEALTH INC (CAH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2025, 16:21.

Change

  • Previous filing in this sequence was filed on 30 Sep 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001504970 Primary reporting owner

Ramakrishna Sudhakar

Relationship
Director
Address
7000 CARDINAL PLACE, DUBLIN
Signature
/s/ James E. Barnett, Attorney-in-fact
Signature date
06 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAH transaction

Common Shares

Award

Transaction value
$0
Shares
+1,067
Change %
+102%
Price
$0.000000
Shares after
2,116
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .